|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
The Solaris Project. A Timing Survey For Circumbinary Planets Around Eclipsing Binary Stars with a Global Network of Robotic Telescopes
If you have a question about this talk, please contact Dr B.-O. Demory.
The Solaris project aims to detect from the ground circumbinary planets with the timing of eclipses of eclipsing binary stars. For the Solaris project, we were granted 2.5 million Euro to establish a network of four robotic 0.5-m telescopes on three continents (Australia, Africa and South America) to carry out high cadence, high precision photometry of a sample of eclipsing binary stars. The last telescope was successfully installed in Argentina In December 2013 and the entire network will soon start regular observing. The project’s web site is www.projectsolaris.eu/.
This effort is accompanied by our radial velocity (RV) survey for circumbinary planets which employs our novel iodine cell based technique tailored to provide very high precision RVs of double-lined binaries. Altogether these two efforts, targeting about 300 eclipsing binary stars, constitute the biggest ground based survey for circumbinary planets.
Moreover, we expect that both these efforts will have a significant impact on the observational stellar astronomy. In particular for at least half of our sample we expect to deliver masses of the stars with an accuracy 10-1000 times better than the current state of the art.
This talk is part of the Exoplanet Meetings series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsHearing Group Meetings Cancer Research UK Cambridge Institute seminars Cambridge Business Lectures
Other talksTransport Scotland Solving the current crisis in the NHS: why the powers that be are missing the point and why they don’t need to. The 2015 Innate Immunity Summit Learning the language of tissue surveillance by T cells Members' Slides Randomization for small clinical trials